Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

ENETS Abstract Search

#3595 Effects of curcumin on proliferation of pancreatic neuroendocrine tumor cells

Introduction: Medical studies have shown that curcumin has the effects of lowering blood lipids, anti-tumor, anti-inflammatory, choleretic and antioxidant. In recent years, domestic and foreign studies have reported that curcumin has an increasingly prominent effect on inhibiting the proliferation of tumor cells, but the effect of curcumin on pancreatic neuroendocrine tumor cells has not been studied.

Conference:

Presenting Author: Han D

Authors: Han D, Du H,

Keywords: Curcumin, Pancreatic Neuroendocrine Tumor, Cells, Inhibitors,

#2146 Clinical Utility (CU) Evaluation of the Health-Related Quality-of-Life (HRQoL) QLQ-GINET21 Questionnaire (QNR) in the Treatment of Patients (pts) with Gastrointestinal (GI) Neuroendocrine Tumors (NETs). QUALINETS Study

Introduction: QLQ-GINET21 for pts with GI-NETs covers muscle/bone pain, body image, information, sexual function, symptoms, social function and disease-related concerns.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Gallego J, Reig O, Sastre J, Garcia I, Segura A,

Keywords: neuroendocrine tumors, Quality of Life, QLQ-GINET21, utility,

#1696 On-going Evaluation of The Clinical Utility of the Health-Related Quality-Of-Life (HRQoL) QLQ-GINET21 Questionnaire (QNR) in the Treatment of Patients (pts) with Gastrointestinal (GI) Neuroendocrine Tumours (NETs). QUALINETS Study

Introduction: Outcome measures reported by pts help to weigh benefit/effect of a therapy on quality of life (QoL), provided that their utility in clinical practice is proved. There are few QoL QNRs for pts with NETs, like QLQ-GINET21, with 21 items assessing muscle/bone pain, body image, information, sexual function, symptoms, social function and disease-related concerns.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Gallego J

Authors: Gallego J, Benavent M, Reig �, Sastre J, Díaz-Pabón I,

Keywords: neuroendocrine tumors, QoL, QLQ-GINET21, utility,

#1292 The Role of 68Ga- DOTA-NOC PET in Evaluating Neuroendocrine Tumors: Real-World Experience from Single Lebanese Institution.

Introduction: Functional imaging with somatostatin analogues have been commonly used in NETs

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Assi R

Authors: Assi R, Shamseddine A, Jreige M, Mukherji D, Abou Said R,

Keywords: NET, Gallium PET,